(Q33753448)

29 July 2017

1 reference

title

F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo (English)

1 reference

29 July 2017

Praticò D

1

1 reference

29 July 2017

1 November 1999

1 reference

29 July 2017

1 reference

29 July 2017

147

1 reference

29 July 2017

1-10

1 reference

29 July 2017

1

1 reference

Autoxidation of polyunsaturated fatty acids: II. A suggested mechanism for the formation of TBA‐reactive materials from prostaglandin‐like endoperoxides

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Peroxy radical cyclization as a model for prostaglandin biosynthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Evidence for the formation of F3-isoprostanes during peroxidation of eicosapentaenoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Isoleukotrienes are biologically active free radical products of lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Mass spectrometric analysis of four regioisomers of F2-isoprostanes formed by free radical oxidation of arachidonic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2 alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Modulation of oxidant stress in vivo in chronic cigarette smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

The isoprostanes: a perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

A nomenclature system for the isoprostanes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Nomenclature of isoprostanes: a proposal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

IPF2alpha-I: an index of lipid peroxidation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Lipid peroxidation: its mechanism, measurement, and significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

The measurement and mechanism of lipid peroxidation in biological systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

8-Epi PGF2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Isoprostanes: potential markers of oxidant stress in atherothrombotic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

The generation and actions of isoprostanes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Identification of the major urinary metabolite of the F2-isoprostane 8-iso-prostaglandin F2alpha in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Identification and measurement of endogenous beta-oxidation metabolites of 8-epi-Prostaglandin F2alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Urinary prostaglandins. Identification and origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Measurement of renal and non-renal eicosanoid synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Identification of two major F2 isoprostanes, 8,12-iso- and 5-epi-8, 12-iso-isoprostane F2alpha-VI, in human urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Measurement of urinary 8-Epi-prostaglandin F2alpha, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/gas chromatography-mass spectrometry. Basal levels in smokers and nonsmokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

PGF2-isoprostanes formed during copper-induced oxidation of low-density lipoproteins are the prostaglandins that cross-react with PGE2 antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Airway and vascular effects of 8-epi-prostaglandin F2 alpha in isolated perfused rat lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

8-Epi-PGF2alpha induces airflow obstruction and airway plasma exudation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

The F2-isoprostane, 8-epi-prostaglandin F2 alpha, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

The F2-isoprostane 8-epiprostaglandin F2alpha increases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Functional characterization of the ocular prostaglandin f2alpha (PGF2alpha) receptor. Activation by the isoprostane, 12-iso-PGF2alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Prostaglandin F2alpha (PGF2alpha) and the isoprostane, 8, 12-iso-isoprostane F2alpha-III, induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Oxidized phospholipids and isoprostanes in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Effect of oxygen tension on the generation of F2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Formation of F2-isoprostanes during aortic endothelial cell-mediated oxidation of low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Increased formation of distinct F2 isoprostanes in hypercholesterolemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Lipid peroxidation associated with successful thrombolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Localization of distinct F2-isoprostanes in human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Oxidative Stress in Chronic Obstructive Pulmonary Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Increased circulating products of lipid peroxidation in patients with alcoholic liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

8-Isoprostaglandin F2 alpha, a product of lipid peroxidation, increases portal pressure in normal and cirrhotic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Aging, energy, and oxidative stress in neurodegenerative diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Oxidative stress hypothesis in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

Increased CSF F2-isoprostane concentration in probable AD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900257-9

10.1016/S0021-9150(99)00257-9

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10525118